A scoping Review Protocol to Explore the Use of Interleukin 1-targeting Drugs for the Treatment of Dermatological Diseases: Indications, Mechanism of Action, Efficacy, and Safety
figure
posted on 2018-04-05, 07:30 authored by Francisco Gómez-García, Juan Ruano, Jesús Gay-Mimbrera, Macarena Aguilar-Luque, Juan L.Sanz-Cabanillas, José L. Hernández Romero, Antonio Velez Garcia-NietoArticle full
text
The article associated with this content has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.
Provide enhanced content for this article
If you are an author of this publication and would like to provide additional enhanced content for your article then please contact adisrapidplus@springer.com.
The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.
Other enhanced features include, but are not limited to:
• Slide decks
• Videos and animations
• Audio abstracts
The article associated with this content has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.
Provide enhanced content for this article
If you are an author of this publication and would like to provide additional enhanced content for your article then please contact adisrapidplus@springer.com.
The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.
Other enhanced features include, but are not limited to:
• Slide decks
• Videos and animations
• Audio abstracts
